一种双酸单胺类型的DOTA:一种潜在的骨向剂
Vojtech Kubícek1, Jakub Rudovský, Jan Kotek
1Laboratory of Organic Chemistry and Catalysis, Delft University of Technology, Julianalaan 136, 2628 BL Delft, The Netherlands.
Journal of the American Chemical Society
|November 25, 2005
概括
开发了一种新的DOTA样联体,BPAMD,用于骨准成像和治疗. 它的Gd(III) 复合体表现出强烈的酸结合,增强了MRI对比潜力.
科学领域:
- 放射化学 放射化学是指辐射化学.
- 核医学就是核医学.
- 材料科学 材料科学 材料科学
背景情况:
- 开发用于骨图像和治疗的向放射性药物的发展至关重要.
- 像DOTA这样的宏循环配体对于稳定的兰化物复合是必不可少的.
- 需要寻找骨的药物来向骨组织输送治疗性放射性核素或成像探针.
研究的目的:
- 设计和合成一个新的宏环DOTA类联结体 (BPAMD) 与一个骨寻找组.
- 评估BPAMD的兰化物复合物的骨图像和治疗潜力.
- 调查Gd(III) -BPAMD在酸上的结合机制和放松性增强.
主要方法:
- 合成和描述BPAMD连接体及其类复合物.
- 1H和31P核磁共振光谱用于复杂的表征.
- 1H和17O放松度研究和1H NMRD测量.
- 使用酸 (HA) 作为骨模型的吸附实验.
- 使用160Tb-BPAMD进行放射化学研究.
主要成果:
- 该Gd(III) -BPAMD复合体证明了有效的吸收和强大的与酸结合.
- 核磁共振研究证实了复合物与骨矿物质表面之间的相互作用.
- 在Gd(III) -BPAMD吸附到HA时,观察到放松性增强.
- 胺二酸部分被确定为关键的骨结合组.
- 放射化学研究显示,160Tb-BPAMD的快速,强烈和可逆吸附到HA上.
结论:
- BPAMD是开发向骨的药物的有前途的配体.
- 胺二 (酸) 组有效地向氧酸.
- Gd(III) -BPAMD显示出作为骨图像的MRI对比剂的潜力.
- 开发的连接体系统对向骨的放射性核素治疗具有前景.
相关概念视频
Antidotes
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


